UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
ROADZEN INC.
111 Anza Boulevard, Suite 109
Burlingame, California 94010
May 9, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street N.E.
Washington, DC 20549
Re: Roadzen Inc.
Application for Withdrawal of Registration Statement on Form S-1 (File No. 333-278706)
Dear Sir or Madam:
On April 16, 2024, Roadzen Inc., a British Virgin Islands business company (the “Company”),... (continue reading...)
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive Proxy Statement
☒
Definitive Additional Materials
☐
Soliciting Material under §... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K MeiraGTx Holdings plc For: May 09
-
Form 8-K ACELYRIN, Inc. For: May 08
-
Form 8-K AstroNova, Inc. For: May 09
-
Form 13F-HR Yelin Lapidot Holdings For: Mar 31
-
Form 8-K Rallybio Corp For: May 09
-
Form 8-K Genprex, Inc. For: May 08
-
Form 8-K CG Oncology, Inc. For: May 09
-
Form D DCC Short Game LLC
-
Form 8-K AstroNova, Inc. For: May 04
-
Form 8-K Endeavor Group Holdings, For: May 09
-
Form 10-Q RAPT Therapeutics, Inc. For: Mar 31
-
Form 8-K Disc Medicine, Inc. For: May 09
-
Form 10-Q Talkspace, Inc. For: Mar 31
-
Form 13F-HR Samson Rock Capital LLP For: Mar 31
-
Form 10-Q Roblox Corp For: Mar 31
-
Form 10-Q Edgewise Therapeutics, For: Mar 31
-
Form 3 Westlake Chemical Partne For: May 08 Filed by: Holy Jeffrey Adam
-
Form 10-Q ACORN ENERGY, INC. For: Mar 31
-
Form S-8 MultiPlan Corp
-
Form 8-K WELLS FARGO & COMPANY/MN For: May 09
-
Form 8-K NeuroBo Pharmaceuticals, For: May 09
-
Form 8-K Phathom Pharmaceuticals, For: May 09
-
Form 8-K ProPhase Labs, Inc. For: May 09
-
Form 8-K Primo Water Corp /CN/ For: May 08
-
Form 8-K Athene Holding Ltd. For: May 09
-
Form 8-K Roblox Corp For: May 09
-
Form 8-K ACORN ENERGY, INC. For: May 09
-
Form 8-K RAPT Therapeutics, Inc. For: May 09
-
Form 8-K ConneXionONE Corp. For: May 08
-
Form 8-K LIFETIME BRANDS, INC For: May 09
-
Form ARS Centessa Pharmaceuticals For: Dec 31
-
Form 8-K Virios Therapeutics, For: May 09
-
Form 10-Q CorMedix Inc. For: Mar 31
-
Form 8-K FIRST MERCHANTS CORP For: May 07
-
Form 497K T. Rowe Price Internatio
-
Form 8-K Edgewise Therapeutics, For: May 09
-
Form 10-Q PMV Pharmaceuticals, For: Mar 31
-
Form 8-K/A ProPhase Labs, Inc. For: Dec 28
-
Form 497K T. Rowe Price Internatio
-
Form 8-K VYNE Therapeutics Inc. For: May 09
-
Form 497 T. Rowe Price Internatio
-
Form 424B2 NMI Holdings, Inc.
-
Form 8-K 180 Life Sciences Corp. For: May 07
-
Form 8-K ANAVEX LIFE SCIENCES For: May 09
-
Form SC 13D Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP
-
Form DEF 14A Centessa Pharmaceuticals For: Jun 25
-
Form 8-K 1606 CORP. For: May 09
-
Form 8-K Azenta, Inc. For: May 07
-
Form 8-K Corbus Pharmaceuticals For: May 09
-
Form 8-K NewAmsterdam Pharma Co For: May 09